Press Releases
CRF Health, a CRF Bracket Company, sees First-in-Class eCOA Solutions Secure 15 Global Dermatology Trials
CRF Health, a CRF Bracket company, the leading provider of patient-centered eSource technology solutions for the life sciences industry, announced the awarding of two new contracts by top-20 pharma companies, which will see the company’s innovative eCOA solutions used...
Press Releases
Aptar Pharma Co-Organizes the Third Edition of RDD Asia in Kerala, India
Aptar Pharma is pleased to announce the co-organization and its diamond sponsorship of the third Respiratory Drug Delivery (RDD®) Asia scientific conference, which will welcome internationally renowned speakers in pulmonary and nasal drug delivery. The conference...
Press Releases
Plasticell receives EU funding as part of €3.7 million consortium to advance neurodegenerative disease research
Plasticell Ltd, a developer of stem cell technologies and regenerative medicines, has announced that the Advanced Stem Cell Training Network (ASCTN), a European research consortium in which the company is a partner organisation, has successfully bid for over €3,700,000...
Press Releases
DefiniGEN licenses CRISPR-Cas9 gene editing technology
DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes. ...
Press Releases
BioBeat unveils 2018’s 50 Movers and Shakers
A new report released unveils 50 female leaders in healthcare business in the UK. Produced by BioBeat, 50 Movers and Shakers in BioBusiness 2018 emphasises the current role of women in leading, inspiring and innovating to ensure new technologies...
Press Releases
Shionogi Announces FDA Approval of XOFLUZA for the Treatment of Acute, Uncomplicated Influenza
Shionogi & Co., Ltd. announced recently that, after completing a Priority Review, the USA FDA has approved XOFLUZA (baloxavir marboxil) for the treatment of acute, uncomplicated influenza in patients 12 years of age and older who have been symptomatic...
Press Releases
Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused company, have entered into a two-year collaborative partnership to deliver validated, platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read